Results 1 to 10 of about 76,288 (243)

A bioinformatic analysis of the spike glycoprotein & evolution of COVID-19

open access: yesMedicine Science, 2022
The Severe Acute Respiratory Syndrome 2 (COVID-19/SARS-CoV-2) has become the pandemic of the century due to its drastically infectious nature. SARS & MERS are the most notable of past coronaviruses infecting merely thousands compared to COVID-19’s ...
Atiksh Chandra, Sathees B Chandra
doaj   +3 more sources

Mechanistic insights into ligand dissociation from the SARS-CoV-2 spike glycoprotein. [PDF]

open access: yesPLoS Computational Biology
The COVID-19 pandemic, driven by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spurred an urgent need for effective therapeutic interventions.
Timothy Hasse   +6 more
doaj   +5 more sources

Spike Glycoprotein-Mediated Entry of SARS Coronaviruses [PDF]

open access: yesViruses, 2020
Severe acute respiratory syndrome coronavirus (SARS-CoV) and SARS-CoV-2 are enveloped, positive-sense, single-stranded RNA viruses and causes of epidemic diseases that have resulted in public health emergencies worldwide. Angiotensin-converting enzyme 2 (
Ye Xiang
exaly   +5 more sources

Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26 [PDF]

open access: yesEmerging Microbes and Infections, 2020
The recent outbreak of pneumonia-causing COVID-19 in China is an urgent global public health issue with an increase in mortality and morbidity. Here we report our modelled homo-trimer structure of COVID-19 spike glycoprotein in both closed (ligand-free ...
Naveen Vankadari, Jacqueline A Wilce
exaly   +5 more sources

The SARS-CoV-2 spike glycoprotein interacts with MAO-B and impairs mitochondrial energetics [PDF]

open access: yesCurrent Research in Neurobiology, 2023
SARS-CoV-2 infection is associated with both acute and post-acute neurological symptoms. Emerging evidence suggests that SARS-CoV-2 can alter mitochondrial metabolism, suggesting that changes in brain metabolism may contribute to the development of acute
Chantal A. Pileggi   +9 more
doaj   +2 more sources

The Human Leukocyte Antigen Class II Immunopeptidome of the SARS-CoV-2 Spike Glycoprotein

open access: yesCell Reports, 2020
Summary: Precise elucidation of the antigen sequences for T cell immunosurveillance greatly enhances our ability to understand and modulate humoral responses to viral infection or active immunization.
Robert W Siegel
exaly   +3 more sources

The Characteristics of Spike Glycoprotein Gene of Swine Acute Diarrhea Syndrome Coronavirus Strain CH/FJWT/2018 Isolated in China

open access: yesFrontiers in Veterinary Science, 2021
Swine acute diarrhea syndrome (SADS) is a highly contagious infectious disease characterized by acute vomiting and watery diarrhea in neonatal piglets.
Yan-Yan Guo   +8 more
doaj   +1 more source

ACE2 overexpressing mesenchymal stem cells alleviates COVID-19 lung injury by inhibiting pyroptosis

open access: yesiScience, 2022
Summary: Mesenchymal stem cells (MSCs) have shown some efficacy in the COVID-19 treatment. We proposed that exogenous supplementation of ACE2 via MSCs (ACE2-MSCs) might have better therapeutic effects.
Jinhuan Wei   +7 more
doaj   +1 more source

SARS‐CoV‐2 spike glycoprotein‐reactive T cells can be readily expanded from COVID‐19 vaccinated donors

open access: yesImmunity, Inflammation and Disease, 2021
Introduction The COVID‐19 vaccine was designed to provide protection against infection by the severe respiratory coronavirus 2 (SARS‐CoV‐2) and coronavirus disease 2019 (COVID‐19).
Pavla Taborska   +5 more
doaj   +1 more source

The screening and evaluation of potential clinically significant HIV drug combinations against the SARS-CoV-2 virus

open access: yesInformatics in Medicine Unlocked, 2021
Spike glycoprotein is essential for the reproduction of the SARS-CoV-2 virus, and its inhibition using already approved antiviral drugs may open new avenues for treatment of patients with the COVID-19 disease.
Draško Tomić   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy